Should You Sell Evaxion Biotech A/S - ADR (EVAX) Stock Tuesday Morning?

Evaxion Biotech A/S - ADR (EVAX) is down Tuesday morning, with the stock decreasing -9.80% in pre-market trading to 1.38. EVAX's short-term technical score of 52 indicates that the stock has traded more bullishly over the last month than 52% of stocks on the market. In the Biotechnology industry, which ranks 66 out of 146 industries, Evaxion Biotech A/S - ADR ranks higher than 50% of stocks. Evaxion Biotech A/S - ADR has risen 15.91% over the past month, closing at $1.50 on May 9. During this period of time, the stock fell as low as $1.48 and as high as $1.78. EVAX has an average analyst recommendation of Strong Buy. The company has an average price target of $11.00.

EVAX has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on EVAX!

See Full EVAX Report

Evaxion Biotech A/S - ADR has a Long-Term Technical rank of 52. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 48% of the market scoring higher. In the Biotechnology industry which is number 65 by this metric, EVAX ranks better than 65% of stocks.

Important Dates for Investors in EVAX:

-Evaxion Biotech A/S - ADR is set to release earnings on 8/29/2023. Over the last 12 months, the company has reported EPS of $-0.98. -We do not have a set dividend date for Evaxion Biotech A/S - ADR at this time. Click Here To Get The Full Report on Evaxion Biotech A/S - ADR (EVAX)